Drugs / 1,1'-METHYLENEBIS(4-((HYDROXYIMINO)METHYL)-PYRIDINIUM)
1,1'-METHYLENEBIS(4-((HYDROXYIMINO)METHYL)-PYRIDINIUM)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02018250 | Mar → Oct 2012 | — | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 1,1'-METHYLENEBIS(4-((HYDROXYIMINO)METHYL)-PYRIDINIUM) | ChEMBL registry synonym — accepted as the source's own label CHEMBL1181952 ↗ |
| Known as | 1,1'-METHYLENEBIS(4-((HYDROXYIMINO)METHYL)-PYRIDINIUM) DIMETHANESULFONATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1181952 ↗ |
| Known as | METHOXIME BROMIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1181952 ↗ |
| Known as | METHOXIME CHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1181952 ↗ |
| Known as | Mmb-4 dimethanesulfonate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1181952 ↗ |
| Known as | MMB4 DMS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02018250 ↗ |
| Modality | Small molecule | — CHEMBL1181952 ↗ |
| Route | Intramuscular | “intramuscular (i.m.) to the anterior thigh” NCT02018250 ↗ |